Clinical Trial Update: Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Argatroban as an anticoagulant alternative to heparin in pediatric patients with thrombocytopenia or thrombosis has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia
• Thrombosis

Drugs mentioned

• Argatroban (argatroban)

Snippet

Sponsor: Encysive Pharmaceuticals | Conditions: Thrombocytopenia, Thrombosis | Phase 4 | Status: COMPLETED